NCT00771810 Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT00748878 Platelet Function During ECMO (Extra Corporeal Membrane Oxygenation) Status COMPLETED Phase N/A
NCT00735930 Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Status COMPLETED Phase PHASE1
NCT00730314 Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells Status COMPLETED Phase PHASE1/PHASE2
NCT00678587 Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures Status TERMINATED Phase PHASE3
NCT00614523 Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) Status COMPLETED Phase PHASE2
NCT00608738 Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment Status COMPLETED Phase NA
NCT00594685 Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study) Status TERMINATED Phase N/A
NCT00508820 An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP Status COMPLETED Phase PHASE3
NCT00501345 Aspirin in Patients With Myocardial Infarction and Thrombocytopenia Status TERMINATED Phase PHASE3
NCT00472290 Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS) Status COMPLETED Phase NA
NCT00471653 Pharmacokinetics in Patients With Newly Diagnosed High-Grade Glioma Receiving Temozolomide and Radiation Therapy Status TERMINATED Phase N/A
NCT00454857 Retrospective & Prospective Observational Study of Patients With Immune (Idiopathic) Thrombocytopenic Purpura (ITP) Status COMPLETED Phase N/A
NCT00418665 A Safety and Efficacy Study to Evaluate AMG 531 Treatment in Subject With Myelodysplastic Syndrome Receiving Revlimid Status COMPLETED Phase PHASE2
NCT00415532 Romiplostim (AMG 531) Versus Medical Standard of Care for Immune (Idiopathic) Thrombocytopenic Purpura Status COMPLETED Phase PHASE3
NCT00413283 Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) Status COMPLETED Phase PHASE2